Argon Medical Devices Modernizes Portal Vein Access with the Launch of the TRAVELER™ Series

PLANO, Texas, March 8, 2023 /PRNewswire/ — Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology, introduces the TRAVELER™ Portal Vein Access Series as the newest addition to its portal vein access product portfolio. The product line is designed to meet the challenging needs of physicians accessing the portal vein through the liver during Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedures. TRAVELER supplements Argon’s notable 2021 launch of SCORPION® which also supports TIPS procedures.

 

TRAVELER is designed to improve component visualization and durability, which are common challenges of the TIPS procedure. “Several innovative features of the TRAVELER set make it easier to access the portal vein compared to other sets on the market. Firstly, the metal cannula is very robust, and the shaping tool allows it to be curved to great degrees without compromising component integrity. Secondly, the puncture needle is longer and seems sharper, making it easier to pass through severely fibrotic liver parenchyma and reach the portal vein, even when there is very distorted anatomy” said Dr. Donna D’Souza, an Interventional Radiologist at the University of Minnesota.

“Our mission is to improve the lives of patients and caregivers through the innovation, manufacturing, and delivery of best-in-class medical devices. Thus, we were compelled to act when we identified an opportunity to simplify complex portal vein access procedures for our customers. We are excited to launch our new TRAVELER products for this purpose and see the positive impact they have on portal access procedures and outcomes in accordance with our mission.” said George Leondis, President & CEO of Argon Medical.

The TRAVELER Series, which includes TRAVELER™16, TRAVELER™21, and TRAVELER™38, is now available in the United States and Canada. “The number of TIPS procedures performed worldwide is increasing as the incidence of liver cirrhosis grows. The advantages offered by our TRAVELER products may make these procedures more efficient for the Interventional Radiologists performing them and the patients they serve.”  said Tom Younker, Senior Vice President of Global Marketing at Argon Medical.

This is the first of multiple new product launches expected from Argon Medical in 2023.

For more information, visit www.argonmedical.com/traveler

About Argon Medical Devices

Since its founding in 1972, Argon Medical Devices earned a reputation for delivering innovative products, superior service, and exceptional value for Interventional Radiologists, Vascular Surgeons, and Interventional Cardiologists worldwide. Argon is proud to have over 1,100 employees, and manufacture products in the United States in Texas, Illinois, New York, and Wisconsin. Argon brands are well-known globally, highlighted by the Option™ELITE IVC Filter, the Cleaner™ Rotational Thrombectomy System, the BioPince™ Ultra Full-core Biopsy Instrument, and  SKATER™ Percutaneous Drainage Catheters. By utilizing a well-established sales and marketing infrastructure, Argon serves its global customers through a direct sales organization, and long-standing relationships with medical device distributors and strategic partners.

Scorpion® is a registered trademark of Hatch Medical, LLC.

 

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PR Newswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, PR Newswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.